<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Interacting with T cells, cytokine-producing B cells play a critical protective role in <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the interaction between malignant B and T cells remains to be fully elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>In a previous study, we have reported that ligation of CCL19-CCR7 and CXCL13-CXCR5 activates paternally expressed gene 10 (<z:chebi fb="0" ids="46550">PEG10</z:chebi>), resulting in an enhancement of apoptotic resistance in B-cell <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>) CD23+CD5+ B cells </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we report that <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> CD23+CD5+ B cells produce IL-10 at high level, which can be further elevated by costimulation with CCL19 and CXCL13 </plain></SENT>
<SENT sid="4" pm="."><plain>CCL19/CXCL13-activated <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> CD23+CD5+ B cells, in turn, increase IL-10 expression in syngeneic CD8+ T cells in a B cell-derived IL-10-dependent manner and requiring a cell-cell contact </plain></SENT>
<SENT sid="5" pm="."><plain>IL-10 secreted from <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> CD23+CD5+ B cells in vitro impairs <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific CTL responses of syngeneic CD8+ T cells </plain></SENT>
<SENT sid="6" pm="."><plain>The impairment of cytotoxicity of syngeneic CD8+ T cells is escalated by means of CCL19/CXCL13-induced up-regulation of IL-10 from <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> CD23+CD5+ B cells </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, using a short hairpin <z:chebi fb="40" ids="33697">RNA</z:chebi> to knockdown <z:chebi fb="0" ids="46550">PEG10</z:chebi>, we provide direct evidence that increased expression of <z:chebi fb="0" ids="46550">PEG10</z:chebi> in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> CD23+CD5+ B cells is involved in malignant B-T cell interaction, contributing to the up-regulation of IL-10 expression, as well as to the impairment of cytotoxicity of syngeneic CD8+ T cells </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, malignant <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> CD23+CD5+ B cells play an immunoregulatory role in controlling different inflammatory cytokine expressions </plain></SENT>
<SENT sid="9" pm="."><plain>IL-10 may be one of the critical cellular factors conferring <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> CD23+CD5+ B cells to escape from host immune surveillance </plain></SENT>
</text></document>